Substance Use Disorder and COVID-19; Forensic Medicine and Pharmacology Perspectives: A Concise Narrative Review

Substance Use Disorder and COVID-19; Forensic Medicine and Pharmacology Perspectives: A Concise Narrative Review

Many investigations have confirmed the link between a substance use disorder (SUD) and the COVID-19 pandemic's increased risk of infection and consequences. This narrative review aims to understand these issues from a pharmacological standpoint, as well as the pandemic's impact on forensic...

Full description

Bibliographic Details
Main Authors:	Ahmed Ali, Torki Al-Zughaibi, Assmaa A. Shaker
Format:	Article
Language:	Arabic
Published:	Naif University Publishing House 2021-12-01
Series:	Arab Journal of Forensic Sciences & Forensic Medicine
Subjects:	forensic science covid 19 sars-cov-2 alcoholism substance use disorder opioids nicotine cannabinoids cocaine methamphetamine
Online Access:	https://journals.nauss.edu.sa/index.php/AJFSFM/article/view/1551

Similar Items

Drugs of abuse in HIV infection and neurotoxicity
by: Melisa eHidalgo, et al.
Published: (2015-03-01)

Current status and future prospects for the development of substance abuse vaccines
by: R. David Heekin, et al.
Published: (2017-11-01)

A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects
by: Celik M, et al.
Published: (2022-09-01)

Sex Differences in Substance Use Disorders: A Neurobiological Perspective
by: Jennifer L. Cornish, et al.
Published: (2021-12-01)

Potassium Channels and Their Potential Roles in Substance Use Disorders
by: Michael T. McCoy, et al.
Published: (2021-01-01)

miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review
by: Carla Occhipinti, et al.
Published: (2023-12-01)

CB2 Receptor Involvement in the Treatment of Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2021-10-01)

Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
by: Alessandra Matzeu, et al.
Published: (2022-01-01)

The Relationship between Substance Use Stigma and COVID-19 Vaccine Hesitancy
by: Natasha Powell, et al.
Published: (2023-07-01)

Substance use disorders: diagnosis and management for hospitalists
by: Ahmed K. Pasha, et al.
Published: (2020-03-01)

Histone modifications in cocaine, methamphetamine and opioids
by: Junzhe Cheng, et al.
Published: (2023-06-01)

Exploring the Role of DARPP-32 in Addiction: A Review of the Current Limitations of Addiction Treatment Pathways and the Role of DARPP-32 to Improve Them
by: Megan R. Greener, et al.
Published: (2022-08-01)

Role of Extracellular Vesicles in Substance Abuse and HIV-Related Neurological Pathologies
by: Katherine E. Odegaard, et al.
Published: (2020-09-01)

Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity
by: Roberto Scendoni, et al.
Published: (2022-11-01)

Editorial: A Changing Epidemic and the Rise of Opioid-Stimulant Co-Use
by: Saeed Ahmed, et al.
Published: (2022-07-01)

Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders
by: Jack Tsai, et al.
Published: (2019-03-01)

The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation
by: Sharanya M Kousik, et al.
Published: (2012-06-01)

Gilles de la Tourette Syndrome and Substance Abuse: A Case Report
by: G. Santos, et al.
Published: (2021-12-01)

Forensic and phramceutical study of the crimes related to illegal trafficking of the narcotic substance cocaine (criminalistics concepts).
by: В. В. Шаповалов
Published: (2016-03-01)

Pattern of substance use among schoolchildren in Palestine: a cross-sectional study
by: Basma R. Damiri, et al.
Published: (2018-10-01)

Smoking, alcohol, and substance use and rates of quitting during pregnancy: is it hard to quit?
by: Yazici AB, et al.
Published: (2016-10-01)

Addiction: Alcohol and Substance Abuse in Judaism
by: Kate Miriam Loewenthal
Published: (2014-09-01)

The Classification of Substance Use Disorders: Historical, Contextual, and Conceptual Considerations
by: Sean M. Robinson, et al.
Published: (2016-08-01)

Does Prenatal Exposure to CNS Stimulants Increase the Risk of Cardiovascular Disease in Adult Offspring?
by: Boyd R. Rorabaugh
Published: (2021-03-01)

Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review
by: Karina Karolina Kedzior, et al.
Published: (2018-05-01)

Driving under the influence of drugs: Correlation between blood psychoactive drug concentrations and cognitive impairment. A narrative review taking into account forensic issues
by: Alberto Blandino, et al.
Published: (2022-01-01)

Depression and Cognitive Impairment in a Spanish Sample of Psychoactive Substance Users Receiving Mental Health Care
by: Bárbara Luque, et al.
Published: (2022-05-01)

Wastewater analysis for nicotine, cocaine, amphetamines, opioids and cannabis in New York City
by: Nicole Centazzo, et al.
Published: (2019-04-01)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2021-05-01)

Addressing overdose risk among unstably housed women in San Francisco, California: an examination of potential fentanyl contamination of multiple substances
by: Meredith C. Meacham, et al.
Published: (2020-03-01)

The hypocretins and the reward function: what have we learned so far?
by: Benjamin eBoutrel, et al.
Published: (2013-06-01)

Current Trends and Perspectives in the Immune Therapy for Substance Use Disorders
by: Octavian Vasiliu
Published: (2022-04-01)

Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis
by: Eduardo R. Butelman, et al.
Published: (2018-06-01)

Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings
by: Marcello Serra, et al.
Published: (2024-01-01)

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations
by: R. R. Cook, et al.
Published: (2023-02-01)

Potential roles of the gut microbiota in the manifestations of drug use disorders
by: Zhiyan Wang, et al.
Published: (2022-12-01)

Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference
by: Ream eAl-Hasani, et al.
Published: (2013-08-01)

Intentional use of both opioids and cocaine in the United States
by: Xiguang Liu, et al.
Published: (2023-06-01)

Drug use and possession, emerging of new psychoactive substances in the West Bank, Palestine
by: Basma Damiri, et al.
Published: (2018-07-01)

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence
by: Justin Matheson, et al.
Published: (2020-05-01)